Ethnobotany, drug development and biodiversity conservation--exploring the linkages

Area of Science:

• Ethnobotany
• Conservation Biology
• Pharmacology

Background:

• Ethnobotanical studies are increasingly vital for identifying novel pharmaceutical products.
• Renewed interest in ethnobotany is driven by governmental and private sector initiatives.
• Interdisciplinary collaboration among anthropologists, botanists, medical scientists, pharmacologists, and chemists is crucial.

Purpose of the Study:

• To link pharmaceutical prospecting with the conservation of traditional medical systems and biological resources.
• To illustrate the concept of an 'ethno-biomedical reserve'.
• To provide a framework for pharmaceutical and herbal industries to support conservation efforts.

Main Methods:

• Establishing the Terra Nova Rainforest Reserve as an ethno-biomedical reserve in Belize.
• Granting legal status to the reserve in June 1993.
• Highlighting the need for sustainable extraction technologies.

Main Results:

• The Belize Ethnobotany Project demonstrates a model for integrating drug discovery with conservation.
• The ethno-biomedical reserve concept offers a pathway for industry involvement in conservation.
• Recognition of the degradation caused by unsustainable resource exploitation.

Conclusions:

• Ethnobotany serves as a critical bridge between pharmaceutical innovation and biodiversity conservation.
• Ethno-biomedical reserves are essential for the sustainable utilization of biological resources.
• Further development of sustainable extraction technologies is imperative to prevent resource degradation.